JPRN-jRCT2031210253已完成3 期
Phase 3 Clinical Study of JTE-061 Cream - Randomized Vehicle-controlled Study (Part 1) and Extension Study (Part 2) in Patients with Plaque Psoriasis
emoto Takanori0 个研究点目标入组 158 人开始时间: 2021年8月18日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 158
研究概览
简要总结
When JTE-061 cream 1% was administered once daily for 12 weeks to patients with plaque psoriasis, improvements in the PGA, PASI, %BSA affected, pruritus NRS, and Skindex-16 were noted as compared to the vehicle cream. When JTE-061 cream 1% was administered once daily for up to 24 weeks to patients with plaque psoriasis, the plasma concentration was low, and treatment with JTE-061 was generally safe. The efficacy of JTE-061 cream 1% in the treatment of plaque psoriasis was maintained for up to 24 weeks.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Japanese patients aged >= 18 years at informed consent who can visit the study site as an outpatient
- •2. Patients with clinical diagnosis of chronic plaque psoriasis and stable disease for at least 6 months at informed consent
- •3. Patients whose PGA score, PASI score, and %BSA affected meet the criteria specified in the study protocol
排除标准
- •1. Patients with psoriasis other than plaque variant
- •2. Patients with a history of or current significant dermatologic or inflammatory condition that, in the investigator's opinion, would make it difficult to interpret data or assessments during the study
- •3. Patients with a history of or current acute active bacterial, fungal, or viral (e.g., herpes simplex, herpes zoster, and varicella) skin infection within 1 week prior to Week 0
- •4. Patients who have used any prohibited therapy specified in the study protocol within the indicated period before Week 0
- •5. Patients with serious concomitant disease(s)
- •6. Patients with a history of or current cancer within 5 years prior to screening visit
研究者
相似试验
招募中
3 期
Phase 3 Clinical Study of JTE-061 Cream - Randomized Vehicle-controlled Study (Double-blind Period) and Extension Study (Extension Period) in Pediatric Patients with Atopic DermatitisAtopic DermatitisJPRN-jRCT2031230139Yamane Satoshi150
进行中（未招募）
3 期
Phase 3 Clinical Study of JTE-061 Cream - 52-week Long-term Study in Patients with Plaque PsoriasisPlaque psoriasisJPRN-jRCT2031210254emoto Takanori300
进行中（未招募）
3 期
Phase 3 Clinical Study of JTE-061 Cream - 52-week Long-term Study in Patients with Atopic DermatitisAtopic DermatitisJPRN-jRCT2031210256emoto Takanori270
已完成
3 期
Phase 3 Clinical Study of JTE-061 Cream - Randomized Vehicle-controlled Study (Part 1) and Extension Study (Part 2) in Patients with Atopic DermatitisAtopic DermatitisJPRN-jRCT2031210255emoto Takanori216
已完成
1 期
Phase 1 Clinical Study of JTE-451 ointment -Single and Multiple Dose StudyPlaque psoriasisJPRN-jRCT2080225252Japan Tobacco Inc.26